MedPath

Dilon Technologies, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery

Not Applicable
Completed
Conditions
Surgical Bleeding
Interventions
Device: HEMOBLASTâ„¢ Bellows
Device: absorbable gelatin sponge with thrombin
First Posted Date
2021-02-02
Last Posted Date
2024-04-02
Lead Sponsor
Dilon Technologies Inc.
Target Recruit Count
60
Registration Number
NCT04734535
Locations
🇺🇸

University of Southern California, Los Angeles, California, United States

🇺🇸

Indiana Spine Group, Carmel, Indiana, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath